Navidea Biopharmaceuticals Market Cap:
292.85M for May 21, 2013Navidea Biopharmaceuticals Historical Market Cap Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| May 21, 2013 | 292.85M |
| May 20, 2013 | 288.15M |
| May 17, 2013 | 281.09M |
| May 16, 2013 | 276.39M |
| May 15, 2013 | 283.44M |
| May 14, 2013 | 281.09M |
| May 13, 2013 | 279.91M |
| May 10, 2013 | 286.97M |
| May 9, 2013 | 276.39M |
| May 8, 2013 | 279.91M |
| May 7, 2013 | 283.44M |
| May 6, 2013 | 289.32M |
| May 3, 2013 | 279.91M |
| May 2, 2013 | 286.97M |
| May 1, 2013 | 282.27M |
| April 30, 2013 | 288.15M |
| April 29, 2013 | 275.21M |
| April 26, 2013 | 283.44M |
| April 25, 2013 | 298.73M |
| April 24, 2013 | 288.15M |
| April 23, 2013 | 285.79M |
| April 22, 2013 | 284.62M |
| April 19, 2013 | 297.56M |
| April 18, 2013 | 305.79M |
| April 17, 2013 | 308.14M |
| April 16, 2013 | 315.20M |
| April 15, 2013 | 291.68M |
| April 12, 2013 | 303.44M |
| April 11, 2013 | 306.96M |
| April 10, 2013 | 310.49M |
| April 9, 2013 | 312.85M |
| April 8, 2013 | 310.49M |
| April 5, 2013 | 311.67M |
| April 4, 2013 | 315.20M |
| April 3, 2013 | 299.91M |
| April 2, 2013 | 297.56M |
| April 1, 2013 | 312.85M |
| March 28, 2013 | 318.73M |
| March 27, 2013 | 322.25M |
| March 26, 2013 | 306.96M |
| March 25, 2013 | 288.15M |
| March 22, 2013 | 299.91M |
| March 21, 2013 | 305.79M |
| March 20, 2013 | 316.37M |
| March 19, 2013 | 324.61M |
| March 18, 2013 | 326.96M |
| March 15, 2013 | 314.02M |
| March 14, 2013 | 342.25M |
| March 13, 2013 | 371.65M |
| March 12, 2013 | 401.05M |
About Market Capitalization
Market Capitalization (Market Cap) is a measurement of business value based on share price and number of shares outstanding. It generally represents the market's view of a company's stock value and is a determining factor in stock valuation.
For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25). Companies can be categorized based upon the size of their market capitalization.
There are five basic groups: mega-cap (market cap over $200B), large-cap ($10B–$200B), mid-cap ($2B–$10B), small-cap ($300M–$2B), and micro-cap ($50M-$300M). Market cap is not always an accurate indication of value because it does not account for debt and other factors.
Learn More
NAVB Market Cap Benchmarks
| Companies | |
|---|---|
| Abiomed | 891.07M |
| Guided Therapeutics | 60.91M |
| Span-America Medical | 55.35M |
NAVB Market Cap Rankings
| Overall |
61st percentile 3088 of 8002 |
| Sector |
56th percentile 297 of 684 in Healthcare |
| Industry |
54th percentile 42 of 93 in Medical Devices |
NAVB Market Cap Range, Past 5 Years
| Minimum | 31.40M | Mar 5 2009 |
| Maximum | 486.70M | May 31 2011 |
| Average | 195.36M |
NAVB News
Business Wire May 15